Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study (Q57480554)

From Wikidata

Jump to navigation Jump to search

article

Language	Label	Description	Also known as
English	Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study	article

Statements

scholarly article

0 references

Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study (English)

0 references

0 references

author name string

José M. Garcia

1

0 references

John Friend

2

0 references

Suzan Allen

3

0 references

publication date

16 June 2012

0 references

Supportive Care in Cancer

0 references

21

0 references

129-137

0 references

1

0 references

https://scigraph.springernature.com/pub.10.1007/s00520-012-1500-1

0 references

The cancer anorexia-cachexia syndrome: myth or reality?

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1500-1

21 January 2018

Mechanisms of cancer cachexia

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1500-1

21 January 2018

Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1500-1

21 January 2018

Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1500-1

21 January 2018

Cancer cachexia: medical management

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1500-1

21 January 2018

Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1500-1

21 January 2018

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1500-1

21 January 2018

Ghrelin enhances appetite and increases food intake in humans

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1500-1

21 January 2018

Effect on body weight and safety of RC-1291, a novel, orally available ghrelin mimetic and growth hormone secretagogue: results of a phase I, randomized, placebo-controlled, multiple-dose study in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1500-1

21 January 2018

Pharmacodynamic hormonal effects of anamorelin, a novel oral ghrelin mimetic and growth hormone secretagogue in healthy volunteers

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1500-1

21 January 2018

Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1500-1

21 January 2018

Pharmacokinetics, safety, and endocrine and appetite effects of ghrelin administration in young healthy subjects.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1500-1

21 January 2018

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1500-1

21 January 2018

Validation of the Edmonton Symptom Assessment Scale.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1500-1

21 January 2018

Association between symptom distress and survival in outpatients seen in a palliative care cancer center.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1500-1

21 January 2018

The Bristol-Myers Anorexia/Cachexia Recovery Instrument (BACRI): a brief assessment of patients' subjective response to treatment for anorexia/cachexia.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1500-1

21 January 2018

Systemic inflammation, nutritional status and survival in patients with cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1500-1

21 January 2018

Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1500-1

21 January 2018

Insulin-like growth factors and neoplasia.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1500-1

21 January 2018

Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1500-1

21 January 2018

Insulin-like growth factor-binding protein-3 suppresses tumor growth via activation of caspase-dependent apoptosis and cross-talk with NF-κB signaling

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1500-1

21 January 2018

Antiangiogenic antitumor activities of IGFBP-3 are mediated by IGF-independent suppression of Erk1/2 activation and Egr-1-mediated transcriptional events

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1500-1

21 January 2018

Anti-cachectic effect of ghrelin in nude mice bearing human melanoma cells

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1500-1

21 January 2018

Growth hormone, insulin, and somatostatin therapy of cancer cachexia

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1500-1

21 January 2018

Concentrations of IGF-I and IGFBP-3 and brain tumor risk in the European Prospective Investigation into Cancer and Nutrition.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1500-1

21 January 2018

Effects by daily long term provision of ghrelin to unselected weight-losing cancer patients: a randomized double-blind study.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1500-1

21 January 2018

Endocrine and non-endocrine activities of growth hormone secretagogues in humans

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1500-1

21 January 2018

ATS/ACCP Statement on cardiopulmonary exercise testing

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1500-1

21 January 2018

Validation of handgrip strength and endurance as a measure of physical function and quality of life in healthy subjects and patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1500-1

21 January 2018

Cancer cachexia and fat-muscle physiology

1 reference

https://pubmed.ncbi.nlm.nih.gov/22699302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care--correlations with food intake, metabolism, exercise capacity, and hormones

1 reference

https://pubmed.ncbi.nlm.nih.gov/22699302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prognostic significance of patient-reported outcomes in pancreatic cancer cachexia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22699302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/22699302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Defining the emetogenicity of cancer chemotherapy regimens: relevance to clinical practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/22699302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of growth hormone and protein intake on tumor growth and host cachexia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22699302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy and survival benefit in elderly patients with advanced non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22699302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of growth hormone on tumor and host in an animal model

1 reference

https://pubmed.ncbi.nlm.nih.gov/22699302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Growth hormone administration reduces circulating proinflammatory cytokines and soluble Fas/soluble Fas ligand system in patients with chronic heart failure secondary to idiopathic dilated cardiomyopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22699302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cachexia: pathophysiology and clinical relevance

1 reference

https://pubmed.ncbi.nlm.nih.gov/22699302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

What is the role of the insulin-like growth factor system in the pathophysiology of cancer cachexia, and how is it regulated?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22699302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00520-012-1500-1

0 references

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57480554&oldid=1933847874"